department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Lisinopril · pharmadog

pharmadog
drugs
Lisinopril

drug

patient view →

lisinopril

Marketedupdated 2mo ago

by CorePharma LLC

Approved

community read0 votes

indications

investigational

Hypertension

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Lisinopril

generic

lisinopril

indication

Congestive Heart Failure (Heart Failure)

phase

marketed

Data sources

ClinicalTrials.gov

last refreshed 31m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Patent cliff

source: FDA Orange Book

first barrier falls

Nov 6, 2035

~9.3 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (12)

Nov 6, 2035method-of-use (U-185)US 10039800
Nov 6, 2035formulationUS 10265370
Nov 6, 2035method-of-use (U-8)US 10406199
Nov 6, 2035formulationUS 10940177
Nov 6, 2035formulationUS 11179434
Nov 6, 2035formulationUS 11771733
Nov 6, 2035formulationUS 12128083
Nov 6, 2035formulationUS 12186360
Nov 6, 2035method-of-use (U-3)US 12433931
Nov 6, 2035formulationUS 9463183
Nov 6, 2035method-of-use (U-71)US 9616096
Nov 6, 2035formulationUS 9814751

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 6

drugZestril8 co-mentions · 2 sources
drugALDACTAZIDE4 co-mentions · 1 sources
tagRecall4 co-mentions · 2 sources
drugritonavir2 co-mentions · 1 sources
drugRitonavir Cipla2 co-mentions · 1 sources
companyCamber Pharmaceuticals Inc2 co-mentions · 1 sources

Trials studying lisinopril

phase3A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemiaterminatedn=1,112
phase2Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeriaterminatedn=66
phase1A Study of Enlicitide Decanoate (MK-0616), Warfarin, and Lisinopril in Healthy Adult Participants (MK-0616-026)completedn=36
phase4Prophylactic Lisinopril to Prevent Anthracycline Cardiomyopathy.withdrawn
phase4Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.terminatedn=14
N/AWomen With Chest Pain and Normal Coronary Arteries Studyterminatedn=3